Recombinant Human Endostatin (Endostar) Combined with Concurrent Intensity Modulated Radiation Therapy for Elderly Local Advanced NSCLC

被引：0
|
作者：
Chen, Q. [1 ]
Xie, Q. [2 ]
Shi, Q. [2 ]
机构：
[1] Fuzhou Pulm Hosp Fujian, Oncol, Fuzhou, Fujian, Peoples R China
[2] Fuzhou Pulm Hosp Fujian, Fuzhou, Fujian, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
Endostar; IMRT; elderly NSCLC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.14-011
引用
收藏
页码：S2178 / S2178
页数：1
相关论文
共 50 条
  • [31] Feasibility study of combined preoperative intensity-modulated radiation therapy (PIMRT) with concurrent capecitabine/oxaliplatin in patients with locally advanced rectal cancer (LARC)
    Arbea Moreno, L.
    Aristu, J.
    Moreno, M.
    Garran, C.
    Nagore, G.
    Valero, J.
    Hernandez, J.
    Sola, J.
    Rodriguez, J.
    Martinez-Monge, R.
    EJC SUPPLEMENTS, 2005, 3 (02): : 183 - 183
  • [32] Recombinant human endostatin combined with intensity-modulated radiotherapy in low-risk locoregionally advanced nasopharyngeal carcinoma: A phase II, randomized, multicenter clinical trial.
    Kang, Min
    Lin, Shaomin
    Zhu, Haisheng
    Liao, Sihui
    Huang, Haixin
    Yu, Bin
    Wang, Hongqian
    Liu, Meilian
    Zhu, Jinxian
    Huang, Guang
    Wang, Fen
    Zhang, Tingting
    Yang, Zhendong
    Zhou, Pingting
    Zhou, Ziyan
    Qin, Yating
    Qin, Yutao
    Wei, Zhuxin
    Zhao, Changhong
    Wang, Rensheng
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [33] CONCURRENT APATINIB AND LOCAL RADIATION THERAPY FOR ADVANCED ESOPHAGEAL ADENOCARCINOMA
    Liu, G.
    Mingyan, E.
    Wang, C.
    He, Y.
    Yin, H.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2019, 33 (04): : 1177 - 1182
  • [34] The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy
    Chen, Chien-Chih
    Wang, Lily
    Lin, Jin-Ching
    Jan, Jian-Sheng
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2015, 114 (03) : 231 - 237
  • [35] Concurrent Chemotherapy and Intensity Modulated Radiation Therapy for Advanced Squamous Cell Carcinomas of the Head and Neck: What is the Appropriate Chemotherapy?
    Suggs, M.
    Giri, S. P.
    Kanakamedala, M. R.
    Hamilton, R. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E305 - E305
  • [36] Intensity-Modulated Radiation Therapy with Concurrent Carboplatin and Paclitaxel for Locally Advanced Head and Neck Cancer: Toxicities and Efficacy
    Vlacich, Gregory
    Diaz, Roberto
    Thorpe, Steven W.
    Murphy, Barbara A.
    Kirby, Fwyndee
    Sinard, Robert J.
    Shakhtour, Bashar
    Shyr, Yu
    Murphy, Patrick
    Netterville, James L.
    Yarbrough, Wendell G.
    Cmelak, Anthony J.
    ONCOLOGIST, 2012, 17 (05): : 673 - 681
  • [37] Preliminary results of concurrent chemotherapy with intensity-modulated radiation therapy (IMRT) for advanced cancer of the larynx/hypopharynx.
    Lee, N.
    Chan, K.
    Zhung, J.
    Wolden, S.
    Su, Y. B.
    Kraus, D.
    Singh, B.
    Shaha, A.
    Shah, J.
    Pfister, D. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 291S - 291S
  • [38] Predictors of Recurrence After Intensity Modulated Radiation Therapy With Concurrent Chemotherapy for Locally Advanced Head-and-Neck Carcinomas
    Baschnagel, A. M.
    Huang, J.
    Warner, J.
    Akervall, J.
    Jaiyesimi, I.
    Gustafson, G.
    Chen, P. Y.
    Krauss, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S469 - S470
  • [39] Endostar combined with intensity-modulated radiotherapy in low-risk local advanced nasopharyngeal carcinoma: A phase II, randomized, multicentric clinical trial.
    Kang, Min
    Lin, Shaomin
    Zhu, Haisheng
    Liao, Sihui
    Huang, Haixin
    Yu, Bin
    Wang, Hongqian
    Liu, Meilian
    Zhu, Jinxian
    Huang, Guang
    Zhang, Tingting
    Yang, Zhendong
    Zhou, Pingting
    Zhou, Ziyan
    Qin, Yutao
    Wei, Zhuxin
    Du, Qinghua
    Zhao, Changhong
    Shen, Mingjun
    Wang, Rensheng
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [40] Chemotherapy Combined With Recombinant Human Endostatin (Endostar) Significantly Improves the Progression-Free Survival of Stage IV Soft Tissue Sarcomas
    Liao, Zhichao
    Zhang, Chao
    Yang, Tielong
    Liu, Haotian
    Yang, Songwei
    Li, Ting
    Xing, Ruwei
    Teng, Sheng
    Yang, Yun
    Zhao, Jun
    Zhao, Gang
    Bai, Xu
    Zhu, Lei
    Yang, Jilong
    FRONTIERS IN ONCOLOGY, 2022, 11
12345